VIDEOS
How the ImmunoINSIGHTS platform is typically used
How the ImmunoINSIGHTS platform is typically used
Strategy of developing preferred supplier agreements with the world’s top BioPharmas
Strategy of developing preferred supplier agreements with the world’s top BioPharmas
The division's H1 performance & expected growth trajectory for the rest of the year
The division's H1 performance & expected growth trajectory for the rest of the year
Possible M&A opportunities
Possible M&A opportunities
Does the group need to consider strengthening its balance sheet?
Does the group need to consider strengthening its balance sheet?
You are watching now.
Update on the EarlyCDT lung cancer test
Update on the EarlyCDT lung cancer test
Why is the yearend being changed from May to Aug?
Why is the yearend being changed from May to Aug?
Future newsflow
Future newsflow
Typical contract values/duration
Typical contract values/duration
Size of orderbook
Size of orderbook
Update on the EarlyCDT lung cancer test
Micro moments from:
Q&A with Oncimmune CEO, Dr Adam M Hill
0 views
4 months ago
Author:
Vox Markets
Powered by
